- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in BioNTech Pfizer
Dermapharm Aims To Start Making Pfizer Shot At Second Site By May
Dermapharm made a "significant share" of the 50 million doses produced in 2020 and is doubling its production capacity to help deliver 75 million extra doses to the European Union in the second quarter
Read MoreExperts, politicians slam Germany for not buying adequate coronavirus vaccine doses
Experts, politicians slam Germany for not buying adequate coronavirus vaccine doses
Read More
COVID-19 Vaccine Sprint As Pfizer-Biontech, Moderna Seek Emergency EU Approval
Pfizer and BioNTech reported final trial results on Nov. 18 that showed their vaccine candidate, known as BNT162b2, was 95% effective in preventing COVID-19, with no major safety concerns.
Read More
Pfizer Files COVID-19 Vaccine Application To US FDA
Pfizer's shares closed up 1.4% and BioNTech shares ended 9.6% higher in New York, as the possibility of a vaccine soon raised hopes for the end of a pandemic that has claimed more than a quarter of a million lives in the United States and over 1.3 million worldwide.
Read More
Pfizer, BioNTech Conclude Phase 3 Study Of COVID-19 Vaccine Candidate, Say It's 95% Effective
The major announcement comes just two days after leading biotechnology company Moderna said on Monday its virus vaccine had an efficacy rate of 94.5 per cent
Read More
Wall Street Dives As Shutdown Worries Overshadow Vaccine Hopes
The Dow Jones Industrial Average fell 344.93 points, or 1.16%, to 29,438.42, the S&P 500 lost 41.74 points, or 1.16%, to 3,567.79 and the Nasdaq Composite dropped 97.74 points, or 0.82%, to 11,801.60.
Read More
Pfizer-BioNTech Vaccine Deliveries Could Start 'Before Christmas'
Global shares rose as the trial results countered concerns around the soaring infection rate. Pfizer shares were up 1.6% while BioNTech jumped 3.8% in the United States. Moderna shares fell 3.6%.
Read More
BioNTech CEO Expects Vaccine Can Be Fridge-Stored For Two Weeks
A good vaccine should have an efficacy of at least 70% to 75% for it to quell the pandemic and that was also the yardstick that BioNTech had set itself.
Read More
Covid-19 Vaccine Status: Here's All You Need To Know
Here is the latest update on COVID-19 vaccines from different pharmaceutical companies
Read More